Absolute treatment effects for the primary outcome and all-cause mortality in the cardiovascular outcome trials in type 2 diabetes: a meta-analysis of individual patient data

被引：0
|
作者：
Kuss, O. [1 ]
Akbulut, C. [2 ]
Schlesinger, S. [2 ]
Georgiev, A. [3 ]
Kelm, M. [4 ]
Roden, M. [3 ]
Wolff, G. [4 ]
机构：
[1] Heinrich Heine Univ, Inst Biometr & Epidemiol, Dusseldorf, Germany
[2] Heinrich Heine Univ, Inst Hlth Serv Res & Hlth Econ, Ctr Hlth & Soc, Dusseldorf, Germany
[3] Heinrich Heine Univ, Inst Clin Diabetol, Dusseldorf, Germany
[4] Univ Hosp Dusseldorf, Cardiol, Pulmonol & Angiol, Dusseldorf, Germany
来源：
EUROPEAN HEART JOURNAL | 2022年 / 43卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2685 / 2685
页数：1
相关论文
共 50 条
  • [1] Absolute treatment effects for the primary outcome and all-cause mortality in the cardiovascular outcome trials of new antidiabetic drugs: a meta-analysis of digitalized individual patient data
    Kuss, Oliver
    Akbulut, Cihan
    Schlesinger, Sabrina
    Georgiev, Asen
    Kelm, Malte
    Roden, Michael
    Wolff, Georg
    [J]. ACTA DIABETOLOGICA, 2022, 59 (10) : 1349 - 1359
  • [2] Absolute treatment effects for the primary outcome and all-cause mortality in the cardiovascular outcome trials of new antidiabetic drugs: a meta-analysis of digitalized individual patient data
    Oliver Kuss
    Cihan Akbulut
    Sabrina Schlesinger
    Asen Georgiev
    Malte Kelm
    Michael Roden
    Georg Wolff
    [J]. Acta Diabetologica, 2022, 59 : 1349 - 1359
  • [3] Effects of insulin on cardiovascular events and all-cause mortality in patients with type 2 diabetes: A meta-analysis of randomized controlled trials
    Mannucci, Edoardo
    Targher, Giovanni
    Nreu, Besmir
    Pintaudi, Basilio
    Candido, Riccardo
    Giaccari, Andrea
    Gallo, Marco
    Monami, Matteo
    [J]. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2022, 32 (06) : 1353 - 1360
  • [4] Effects of pioglitazone on cardiovascular events and all-cause mortality in patients with type 2 diabetes: A meta-analysis of randomized controlled trials
    Mannucci, Edoardo
    Giaccari, Andrea
    Gallo, Marco
    Targher, Giovanni
    Pintaudi, Basilio
    Candido, Riccardo
    Monami, Matteo
    [J]. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2022, 32 (03) : 529 - 536
  • [5] ASPIRIN FOR PRIMARY PREVENTION OF CARDIOVASCULAR AND ALL-CAUSE MORTALITY: A META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS
    Alrifai, A.
    Al Halabi, S.
    Rosenstein, R. S.
    [J]. CARDIOLOGY, 2015, 131 : 93 - 93
  • [6] Television Viewing and Risk of Type 2 Diabetes, Cardiovascular Disease, and All-Cause Mortality A Meta-analysis
    Grontved, Anders
    Hu, Frank B.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2011, 305 (23): : 2448 - 2455
  • [7] Aspirin for primary prevention of cardiovascular and all-cause mortality events in diabetes: updated meta-analysis of randomized controlled trials
    Kunutsor, S. K.
    Seidu, S.
    Khunti, K.
    [J]. DIABETIC MEDICINE, 2017, 34 (03) : 316 - 327
  • [8] Legacy effects of statins on cardiovascular and all-cause mortality: a meta-analysis
    Nayak, Agnish
    Hayen, Andrew
    Zhu, Lin
    McGeechan, Kevin
    Glasziou, Paul
    Irwig, Les
    Doust, Jenny
    Gregory, Gabriel
    Bell, Katy
    [J]. BMJ OPEN, 2018, 8 (09):
  • [9] Periodontal disease and subsequent risk of cardiovascular outcome and all-cause mortality: A meta-analysis of prospective studies
    Guo, Xiangyu
    Li, Xue
    Liao, Chunjuan
    Feng, Xingyu
    He, Tao
    [J]. PLOS ONE, 2023, 18 (09):
  • [10] Oat Intake and Risk of Type 2 Diabetes, Cardiovascular Disease and All-Cause Mortality: A Systematic Review and Meta-Analysis
    Wehrli, Faina
    Taneri, Petek E.
    Bano, Arjola
    Bally, Lia
    Blekkenhorst, Lauren C.
    Bussler, Weston
    Metzger, Brandon
    Minder, Beatrice
    Glisic, Marija
    Muka, Taulant
    Kern, Hua
    [J]. NUTRIENTS, 2021, 13 (08)
12345